Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Nashville news?

Get a daily digest of the most important stories affecting your hometown with the Axios Nashville newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Columbus news?

Get a daily digest of the most important stories affecting your hometown with the Axios Columbus newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Dallas news?

Get a daily digest of the most important stories affecting your hometown with the Axios Dallas newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Marvel

Disney's latest Marvel blockbuster, "Shang-Chi and the Legend of the Ten Rings" has officially beaten Disney's other Marvel hit "Black Widow" in North American ticket sales, according to the latest figures from Comscore.

Why it matters: The success of both films points to the extraordinary power of the Marvel franchise in luring people to the box office, even as the pandemic drags on.

Data: The Numbers; Chart: Andrew Witherspoon/Axios

Be smart: The film has so far brought in nearly $187 million in North American theater ticket sales, and nearly $331 million worldwide.

  • For now, it lags behind "Black Widow" just slightly on the global stage, but it could surpass the movie in total box office sales globally in coming weeks.

Flashback: "Shang-Chi" obliterated Labor Day weekend box office records, bringing in $94 million for the full four-day weekend, per Comscore. That early momentum has continued, despite COVID-19 cases surging in some parts of the U.S.

Be smart: The film's global box office success is especially noteworthy, given that the movie has still not been approved by China's government to run in the country's theaters. It's looking increasingly likely that the film may never get a release date in China, despite Disney's best efforts.

  • "Even without a China release date, the film is an unqualified box office hit and will undoubtedly be a huge hit on the small screen of when it makes its debut there," said Comscore senior media analyst Paul Dergarabedian.

The big picture: In recent years, box office ticket sales have skewed more heavily toward action and adventure movies from popular franchises like Marvel, Star Wars and the Avengers, while the share of ticket sales for dramas and comedies has fallen.

  • Action movies lend themselves to higher-end film experiences on big screens, compared to more passive, low-budget films like dramas.
  • While theater ticket sales have experienced strong momentum in the past few months, analysts don't expect the box office to recover meaningfully until 2022.

What to watch: It's been a good year for Disney at the box office, thanks in large part to the success of its Marvel movies. But the company, which has over a dozen additional Marvel films slated for the next few years, could be facing some trouble.

  • Marvel sued Disney on Friday for copyright termination protections of Marvel's Avengers characters, per the Hollywood Reporter.

What's next: Disney announced last week that "Shang-Chi" will be made available on its streaming service Disney+ at no additional cost to subscribers on Nov. 12.

Go deeper

Broadway's “Aladdin” temporarily goes dark after new COVID cases

The "Aladdin" Broadway musical displayed outside the New Amsterdam Theatre on Oct. 1 in New York City. Photo: Angela Weiss/AFP via Getty Images

The Broadway hit “Aladdin” announced Friday it temporarily put Genie back in the lamp and canceled all future shows until Oct. 12 because of breakthrough COVID-19 cases among cast members.

Why it matters: The show had just reopened Tuesday after being dark for 18 months because of the coronavirus pandemic.

34 mins ago - World

"I assume full responsibility," Duterte says of drug war

Rodrigo Duterte in 2017. Photo: Linus Escandor II/AFP via Getty Images

Philippines President Rodrigo Duterte said Thursday that he assumes full responsibility for a violent war on drugs that has killed thousands of people, Reuters reported.

Why it matters: Last month the International Criminal Court (ICC) formally authorized an investigation into alleged crimes against humanity during Duterte's war on drugs.

CDC approves boosters for Moderna and J&J and mix-and-match

Boxes containing vials of the Janssen COVID-19 vaccine. Photo: Jon Cherry/Getty Images

The Centers for Disease Control and Prevention's independent advisory panel voted unanimously to recommend booster doses of Moderna and Johnson & Johnson vaccine and allow people to mix-and-match doses.

The big picture: The agency aligns with the Food and Drug Administration authorization Wednesday night which said people could switch to whichever vaccine they wanted for their booster shot.